글로벌 뇌 양전자 방출 단층촬영(PET) - 자기공명영상(MRI) 시스템 시장 – 2030년까지의 산업 동향 및 예측

뇌 양전자 방출 단층촬영(PET) - 자기공명영상(MRI) 시스템 시장 분석 및 규모

양전자 방출 단층촬영(PET)-자기 공명 영상(MRI) 시스템은 암, 심장병 및 뇌 질환의 조기 징후를 감지하는 데 사용되는 하이브리드 의료 영상 기술을 기반으로 하는 의료 기기 입니다 . 양전자 방출 단층촬영(PET)-자기 공명 영상(MRI) 시스템은 연조직 형태학적 영상 기술과 위치 방출 단층촬영 기능적 영상 기술을 통합합니다. 전 세계적으로 신경 질환의 유병률이 급증하는 것은 시장 성장을 촉진하는 주요 요인 중 하나입니다. 고해상도 및 3차원 영상을 제공하는 의료 기술 발전에 대한 집중도가 높아지고 암 발병률이 증가하는 것은 또 다른 시장 성장 결정 요인입니다. 연구 개발 능력 향상과 개인 가처분 소득 증가는 수익성 있는 시장 성장 기회를 더욱 창출할 것입니다.             

Data Bridge Market Research는 2022년에 1억 6,890만 달러였던 뇌 위치 방출 단층촬영(PET)-자기 공명 영상(MRI) 시스템 시장이 2030년까지 3억 5,690만 달러로 성장할 것으로 예상하고, 2023-2030년 예측 기간 동안 4.80%의 CAGR을 기록할 것으로 분석했습니다. "전통적인 양전자 방출 단층촬영(PET)-자기 공명 영상(MRI) 시스템"은 인구 중 뇌 질환이 증가함에 따라 글로벌 뇌 양전자 방출 단층촬영(PET)-자기 공명 영상(MRI) 시스템 시장의 제품 부문을 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

뇌 양전자 방출 단층촬영(PET) - 자기공명영상(MRI) 시스템 시장 범위 및 세분화

Market Definition

A radiotracer, a small amount of radioactive material used in brain PET, allows doctors to see the brain's metabolic and biochemical activities. Various brain problems, including tumors, strokes, multiple sclerosis, traumatic brain injuries, and neurodegenerative diseases, can be diagnosed and monitored with MRI scans. Both brain PET and MRI systems are potent instruments that offer complimentary details about the anatomy and function of the brain, enabling medical professionals to comprehend and diagnose various neurological diseases more accurately.

Brain Positron Emission Tomography (PET) - Magnetic Resonance Imaging (MRI) Systems Market Dynamics

Drivers

• Increasing Prevalence of Neurological Disorders

Due to causes including aging populations and changing lifestyles, neurological disorders like Alzheimer’s disease, Parkinson’s disease, stroke, brain tumors, and epilepsy are becoming increasingly common. The demand for cutting-edge imaging techniques like PET and MRI for early detection, precise diagnosis, and disease monitoring has increased due to the rising prevalence of these disorders. Thus increase in the incidence rates of neuro diseases is acting as a driver for the market growth.

• Rising Technological Advancements

PET and MRI systems' performance, resolution, and speed have considerably increased thanks to ongoing developments in imaging technology. These developments include better detectors, stronger magnets, quicker image acquisition, and enhanced image reconstruction algorithms. Additionally, hybrid PET/MRI systems have been developed, enabling the simultaneous gathering of structural and functional data.

• Improved Diagnostics and Personalized Medicine

A precise diagnosis and effective treatment planning are made possible by the detailed anatomical and functional information about the brain provided by PET and MRI. These imaging techniques can spot minute alterations in brain anatomy and anomalies in blood flow, metabolism, and neuronal activity. Using this knowledge, treatment plans can be customized for certain patients based on their unique brain traits, supporting personalized medicine.

Opportunities

• Increasing R and D Activities

Research has concentrated on improving image quality by developing more sensitive detectors, optimizing imaging protocol, and reconstruction algorithms. For MRI and PET, researchers are constantly investigating and creating new radiotracers. To shed light on a variety of neurological diseases, radiotracers are made to target particular biological functions or chemicals in the brain specifically. Higher resolution, an enhanced signal-to-noise ratio, and more excellent overall image quality are the results of this, enabling more accurate visualization of brain structures and disorders.

• Rising Focus on Healthcare Infrastructure

As the healthcare infrastructure develops, an increased emphasis is being placed on purchasing cutting-edge medical equipment, such as PET and MRI scanners. These imaging systems are more likely to be purchased and installed by hospitals, clinics, and medical facilities in order to improve their diagnostic capabilities and deliver comprehensive healthcare services. The availability of PET and MRI equipment has increased due to the expansion of the healthcare infrastructure, including the construction of hospitals in both urban and rural locations. Patients no longer need to travel great distances for imaging services because they have improved access to this diagnostic equipment.

• Growing Patient Awareness

Patients are learning more about the capabilities and uses of PET and MRI systems as public knowledge of these imaging modalities increases. Patients are becoming increasingly aware of the valuable information that PET and MRI scans can provide about the brain's structure, function, and pathology. This knowledge enables patients to actively participate in their healthcare decisions, have informed conversations with healthcare professionals, and ask pertinent questions.

Restrains/Challenges

• Strict Regulations for the Approval of Devices

Different nations and areas have different rules and regulations governing brain MRI and PET imaging technologies. The approval, clearance, and regulation of PET and MRI systems are closely supervised by regulatory agencies, such as the U.S. Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in the European Union. Manufacturers, healthcare professionals, and end users must abide by these bodies' standards, regulations, and recommendations. Before being put on the market and used for clinical purposes, PET and MRI systems normally undergo a rigorous approval and certification process. Device makers must show that their products meet the quality, performance, and safety requirements established by regulatory bodies. Inspections, testing, and pre-market reviews may be a part of the approval procedure.

• Limited Accessibility

Despite increased usage and accessibility of PET and MRI equipment, some isolated or regional areas may still have restricted access. In some places, the infrastructure necessary to support various imaging modalities and the availability of trained personnel may need to be improved. Due to this, patients, especially those in impoverished areas, have varying levels of access to brain PET and MRI scans.  Thus, limited accessibility in certain regions may hamper the market growth.

• Lack of Skilled Professionals

MRI and PET equipment must be operated safely and effectively, which requires highly skilled medical personnel. To gather, interpret, and correctly analyze imaging data, radiologists, technicians, and doctors must receive specialized training. The availability of such specialised training programs and the requirement for ongoing education might be a barrier, especially in areas with constrained training resources.

• High Cost of Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI)

Imaging devices like MRI and PET are complex and expensive. Particularly for smaller healthcare facilities or those in environments with limited resources, the high initial cost of purchasing and implementing these systems can be a substantial barrier. Healthcare providers may also need financial assistance as a result of the continuing maintenance, operation, and upgrade expenditures, which would limit their capacity to invest in these systems.

This global brain positron emission tomography (PET) - magnetic resonance imaging (MRI) systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global brain positron emission tomography (PET) - magnetic resonance imaging (MRI) systems market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed market decision to achieve market growth.

Global Brain Positron Emission Tomography (PET) - Magnetic Resonance Imaging (MRI) Systems Market Scope

The global brain positron emission tomography (PET)- magnetic resonance imaging (MRI) systems market is segmented on the basis of phase, product, and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with valuable market overviews and market insights to help them make strategic decisions to identify core market applications.

Phase

•  Clinical
• Pre-clinical

Product

• Traditional Positron Emission Tomography (PET)- Magnetic Resonance Imaging (MRI) Systems
• Helium-Free Positron Emission Tomography (PET)- Magnetic Resonance Imaging (MRI) System

End use

• Hospitals
• Diagnostic Imaging Centres
• Others

Brain Positron Emission Tomography (PET) - Magnetic Resonance Imaging (MRI) Systems Market Regional Analysis/Insights

The market of brain positron emission tomography (PET) - magnetic resonance imaging (MRI) systems is analyzed. Market size insights and trends are provided by country, phase, product, and end-use as referenced above.

The countries covered in the brain positron emission tomography (PET) - magnetic resonance imaging (MRI) systems market report are the U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America

North America dominates the brain positron emission tomography (PET) magnetic resonance imaging (MRI) systems market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increasing adoption by research centres, growth and expansion of healthcare industry in this region and growing prevalence of cancer.

아시아 태평양 지역은 신경계 질환의 유병률이 증가함에 따라 2023년부터 2030년까지 성장할 것으로 예상됩니다.

뇌 양전자 방출 단층촬영(PET) - 자기공명영상(MRI) 시스템 시장 보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 추세에 영향을 미치는 규제 변화를 제공합니다. 소비량, 생산 현장 및 양, 수입 수출 분석, 가격 추세 분석, 원자재 비용, 하류 및 상류 가치 사슬 분석과 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

의료 인프라 성장 설치 기반 및 신기술 침투

글로벌 뇌 양전자 방출 단층촬영(PET)-자기 공명 영상(MRI) 시스템 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 글로벌 뇌 양전자 방출 단층촬영(PET)-자기 공명 영상(MRI) 시스템 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용하는 기술의 영향, 의료 규제 시나리오의 변화 및 글로벌 뇌 양전자 방출 단층촬영(PET)-자기 공명 영상(MRI) 시스템 시장에 미치는 영향. 이 데이터는 2015년부터 2020년까지의 과거 기간에 대한 데이터를 제공합니다.

경쟁 환경 및 글로벌 뇌 양전자 방출 단층촬영(PET) - 자기공명영상(MRI) 시스템 시장 점유율 분석

글로벌 뇌 양전자 방출 단층촬영(PET) - 자기공명영상(MRI) 시스템 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 글로벌 뇌 양전자 방출 단층촬영(PET) - 자기공명영상(MRI) 시스템 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 뇌 양전자 방출 단층촬영(PET)-자기공명영상(MRI) 시스템 시장에서 운영되는 주요 업체는 다음과 같습니다.

• 히타치 주식회사(일본)
• Seimens Healthcare GmbH(독일)
• CANON MEDICAL SYSTEMS CORPORATION(일본)
• 제너럴 일렉트릭 컴퍼니(미국)
• 브루커(미국)
• FONAR Corp. (미국)
• Koninklijke Philips NV(네덜란드)
• Aspect Imaging Ltd. (미국)
• 오로라 헬스케어(미국)
• Neusoft Corporation(중국)
• TOSHIBA CORPORATION(일본)
• 산라드(인도)
• ONEX Corporation(캐나다)
• 홀로직 주식회사(미국)
• 후지필름 주식회사(일본)
• ESAOTE SPA(이탈리아)
• 마그리텍(독일)
• 심천 Mindray Bio-Medical Electronics Co., Ltd. (중국)
• Quality Electrodynamics, LLC(미국)
• 심천 안케 하이테크 유한회사(중국)

SKU-65724